
McKesson drives growth with oncology, strong cash flow, and share buybacks in US pharma market
McKesson, a leading pharmaceutical distributor in the US oligopoly, generates over $5 billion in free cash flow and is expanding through its oncology segment, which saw a 31% revenue increase year-over-year. The company is strategically acquiring bus...


